Prospective Study of Risk-Reducing Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer
Principal Investigator
,
Status
Terminated
Date of Study Termination
April 10 2020
Disease Site
Gynecologic [GY]
Ovarian
Phase
I
Developmental Therapeutics
No
Primary Objective
To determine the prospective incidence of OC, fallopian tube cancer, breast cancer, PPC, and all cancer among women at increased risk of OC, with a special emphasis on women who are known BRCA1/2 mutation carriers.
Patient Population
Target Accrual
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.